Author:
Jin Shiguang,Li Xueping,Dai Yan,Li Cheng,Wang Daxin
Funder
Natural Science Foundation of Yangzhou
Jiangsu Provincial Commission of Health and Family Planning
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Molecular Medicine,General Medicine
Reference36 articles.
1. Z.T. Bing, G.H. Yang, J. Xiong, L. Guo, L. Yang, Identify signature regulatory network for glioblastoma prognosis by integrative mRNA and miRNA co-expression analysis. IET Syst. Biol. 10, 244–251 (2016)
2. T.A. Dolecek, J.M. Propp, N.E. Stroup, C. Kruchko, CBTRUS statistical report: Primary brain and central nervous system tumors diagnosed in the United States in 2005–2009. Neuro-Oncology 14(Suppl 5), v1–v49 (2012)
3. R. Stupp, W.P. Mason, V.D.B. Mj, M. Weller, B. Fisher, M.J. Taphoorn, K. Belanger, A.A. Brandes, C. Marosi, U. Bogdahn, Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. Clin. Med. Oncol. 2, 421–422 (2008)
4. U. Linz, Commentary on effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial (Lancet Oncol. 2009;10:459–466). Cancer 116, 1844–1846 (2010)
5. E. Kaur, J.S. Goda, A. Ghorai, S. Salunkhe, P. Shetty, A.V. Moiyadi, E. Sridhar, A. Mahajan, R. Jalali, S. Dutt, Molecular features unique to glioblastoma radiation resistant residual cells may affect patient outcome – a short report. Cell. Oncol. 42, 107–116 (2019)
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献